Toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin ineligible head and neck cancer patients.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18022
Abstract: e18022Background: Docetaxel can be administered in several situations like low creatinine clearance or pre existing grade 3-4 ototoxicity, where cisplatin is contraindicated. In this analysis, we p... read more here.
Keywords: tolerance concurrent; cisplatin; concurrent docetaxel; toxicity tolerance ... See more keywords